Fasinumab

(3aR,4R,6E,9S,10E,11aR)-2,3,3a,4,5,8,9,11a-Octahydro-9-hydroxy-6,10-dimethyl-3-methylene-2-oxocyclodeca[b]furan-4-yl (2E)-4-hydroxy-2-methyl-2-butenoate (ACI)

Gantenerumab

Benralizumab

Rontalizumab

(1aR,2E,4aR,6S,7S,7aR,8R,9Z,11aS)-4a,8-Bis(acetyloxy)-9-[(acetyloxy)methyl]-7-(benzoyloxy)-1,1a,4a,5,6,7,7a,8,11,11a-decahydro-1,1,3,6-tetramethyl-4H-cyclopenta[a]cyclopropa[f]cycloundecen-4-one (ACI)

Immunoglobulin G1, anti-(human interleukin 9) (human-Mus musculus monoclonal MEDI-528 heavy chain), disulfide with human-Mus musculus monoclonal MEDI-528 κ-chain, dimer (ACI)

Racotumomab

Urelumab

Immunoglobulin G1, anti-(human interleukin 1α) (human monoclonal MABp1 heavy chain), disulfide with human monoclonal MABp1 κ-chain, dimer (ACI)

Angiotensin-converting enzyme (ACI)

Endo-1,3-β-glucanase (ACI)

Phospholipase A2 (9CI, ACI)

Thermolysin (9CI, ACI)

Lucatumumab

Immunoglobulin G1, anti-(human interleukin 15) (human monoclonal AMG 714 γ1-chain), disulfide with human monoclonal AMG 714 κ-chain, dimer (ACI)

Dacetuzumab

1,1-Dimethylethyl N-[(2R,6S,12Z,13aS,14aR,16aS)-14a-[[(cyclopropylsulfonyl)amino]carbonyl]-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydro-2-hydroxy-5,16-dioxocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-6-yl]carbamate (ACI)

1-Methyl-2-[2-[(1-methylnaphtho[1,2-d]thiazol-2(1H)-ylidene)methyl]-1-buten-1-yl]naphtho[1,2-d]thiazolium (ACI)

5-(4-Hydroxyphenyl)-3H-1,2-dithiole-3-thione